Literature DB >> 24580742

Patients who present late to HIV care and associated risk factors in Nigeria.

P A Agaba1, S T Meloni, H M Sule, O O Agbaji, P N Ekeh, G C Job, N Nyango, P O Ugoagwu, G E Imade, J A Idoko, P J Kanki.   

Abstract

OBJECTIVES: Our objectives were to assess trends in late presentation and advanced HIV disease (AHD) and determine associated risk factors.
METHODS: We conducted a retrospective cohort analysis of patients who had received care and treatment at the AIDS Prevention Initiative Nigeria Plus (APIN)/Harvard School of Public Health-President's Emergency Plan for AIDS Relief (PEPFAR) programme at the Jos University Teaching Hospital, Jos, Nigeria from 2005 to 2010. We used the European Consensus Definition to assess trends in late presentation (CD4 count < 350 cells/μL or AIDS-defining illness) and AHD (CD4 count < 200 cells/μL or AIDS-defining illness) and evaluated associated risk factors using logistic regression methods.
RESULTS: Among 14,487 eligible patients, 12,401 (85.6%) were late presenters and 9127 (63.0%) presented with AHD. Late presentation decreased from 88.9% in 2005 to 80.1% in 2010 (P < 0.001). Similarly, AHD decreased from 67.8% in 2005 to 53.6% in 2010 (P < 0.001). In logistic regression models adjusting for sociodemographic and biological variables, male sex [adjusted odds ratio (aOR) = 1.80; 95% confidence interval (CI) 1.60-2.04], older age (aOR = 1.37; 95% CI 1.22-1.54), civil service employment (aOR = 1.48; 95% CI 1.00-2.21), referral from out-patient (aOR = 2.18; 95% CI 1.53-3.08) and in-patient (aOR = 1.55; 95% CI 1.11-2.17) services, and hepatitis B virus (aOR = 1.43; 95% CI 1.26-1.63) and hepatitis C virus (aOR = 1.18; 95% CI 1.02-1.37) coinfections were associated with late presentation. Predictors of AHD were male sex (aOR = 1.67; 95% CI 1.54-1.82), older age (aOR = 1.26; 95% CI 1.16-1.36), unemployment (aOR = 1.34; 95% CI 1.00-1.79), referral from out-patient (aOR = 2.40; 95% CI 1.84-3.14) and in-patient (aOR = 1.97; 95% CI 1.51-2.57) services and hepatitis B virus coinfection (aOR = 1.30; 95% CI 1.19-1.42).
CONCLUSIONS: Efforts to reduce the proportion of patients who first seek care at late stages of disease are needed. The identified risk factors should be utilized in formulating targeted public health interventions to improve early diagnosis and presentation for HIV care.
© 2014 British HIV Association.

Entities:  

Keywords:  HIV; Nigeria; advanced HIV disease; late presentation; risk factors

Mesh:

Year:  2014        PMID: 24580742     DOI: 10.1111/hiv.12125

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  16 in total

1.  Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men.

Authors:  Muktar H Aliyu; Meridith Blevins; Karen M Megazzini; Deidra D Parrish; Carolyn M Audet; Naomi Chan; Chisom Odoh; Usman I Gebi; Mukhtar Y Muhammad; Bryan E Shepherd; C William Wester; Sten H Vermund
Journal:  Int Health       Date:  2015-05-25       Impact factor: 2.473

Review 2.  Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa.

Authors:  Monisha Sharma; Roger Ying; Gillian Tarr; Ruanne Barnabas
Journal:  Nature       Date:  2015-12-03       Impact factor: 49.962

3.  Prevalence and Risk Factors of Mortality among Adult HIV Patients Initiating ART in Rural Setting of HIV Care and Treatment Services in North Western Tanzania: A Retrospective Cohort Study.

Authors:  Daniel Wilfred Gunda; Igembe Nkandala; Semvua Bukheti Kilonzo; Boniface Bartholomew Kilangi; Bonaventura Cornel Mpondo
Journal:  J Sex Transm Dis       Date:  2017-06-15

4.  Demographic and clinical correlates of HIV-1 RNA levels in antiretroviral therapy-naive adults attending a tertiary hospital in Jos, Nigeria.

Authors:  Joseph Anejo-Okopi; Isaac Okoh Abah; Yakhat Barshep; Augustine Odo Ebonyi; Comfort Daniyam; Samson Ejiji Isa; Gomerep Simji; Stephen Oguche; Patricia Agaba; Patricia Lar; Oche Agbaji; John A Idoko
Journal:  J Virus Erad       Date:  2017-01-01

5.  High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra Leone.

Authors:  George A Yendewa; Eva Poveda; Sulaiman Lakoh; Sahr A Yendewa; Darlinda F Jiba; Angel Salgado-Barreira; Foday Sahr; Robert A Salata
Journal:  Open Forum Infect Dis       Date:  2018-08-23       Impact factor: 3.835

6.  Late presentation to HIV/AIDS care at the Douala general hospital, Cameroon: its associated factors, and consequences.

Authors:  Henry Namme Luma; Paulia Jua; Olivier-Tresor Donfack; Felicite Kamdem; Eveline Ngouadjeu; Hugo Bertrand Mbatchou; Marie-Solange Doualla; Yakouba Njankou Mapoure
Journal:  BMC Infect Dis       Date:  2018-07-03       Impact factor: 3.090

7.  Predictors of Late HIV Diagnosis among Adult People Living with HIV/AIDS Who Undertake an Initial CD4 T Cell Evaluation, Northern Ethiopia: A Case-Control Study.

Authors:  Melkamu Bedimo Beyene; Habtamu Bedimo Beyene
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

8.  Determinants of late presentation to HIV/AIDS care in Southern Tigray Zone, Northern Ethiopia: an institution based case-control study.

Authors:  Yalemzewod Assefa Gelaw; Goitom Halefom Senbete; Akelew Awoke Adane; Kefyalew Addis Alene
Journal:  AIDS Res Ther       Date:  2015-12-02       Impact factor: 2.250

9.  Advanced HIV disease at presentation to care in Nairobi, Kenya: late diagnosis or delayed linkage to care?--a cross-sectional study.

Authors:  Mia Liisa van der Kop; Lehana Thabane; Patricia Opondo Awiti; Samuel Muhula; Lennie Bazira Kyomuhangi; Richard Todd Lester; Anna Mia Ekström
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090

10.  A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe.

Authors:  Malebogo Tlhajoane; Tidings Masoka; Edith Mpandaguta; Rebecca Rhead; Kathryn Church; Alison Wringe; Noah Kadzura; Nimalan Arinaminpathy; Constance Nyamukapa; Nadine Schur; Owen Mugurungi; Morten Skovdal; Jeffrey W Eaton; Simon Gregson
Journal:  Health Res Policy Syst       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.